Increased prescription dose for large vessel intravascular brachytherapy

Kent Wallner, Kathleen E. Kearney, Jasleen Tiwana, Nicole Pristera, Edward Y. Kim, Lorenzo Azzalini, George Sandison, William L. Lombardi, Creighton Don, Minsun Kim

Research output: Contribution to journalArticlepeer-review


Background: Most randomized studies testing the effectiveness of IVBT were limited to vessels less than 4 mm diameter. In fact, it is now common to treat vessels larger than 4 mm. Accordingly, the authors instituted a prescription dose increase to 34 Gy at 2 mm from source center for vessels greater than 4.0 mm. The increase in prescription dose to 34 Gy at 2 mm from center is substantial, being 50% higher than the conventional maximum of 23 Gy. Aim: To take a close look at group of patients treated to 34 Gy, and for whom follow-up angiograms are available. Methods: Ten patients treated for ISR with a prescription dose of 34 Gy and for whom follow-up angiograms were available were studied. Beta-radiation brachytherapy was performed with a Novoste Beta-Cath System using a strontium-90 (beta) source (Best Vascular, Springfield, VA). Source lengths of 40 or 60 mm were used. A dose of 34 Gy was prescribed at 2 mm from the source center. Results: Patients were re-catheterized from 2 to 21 months (median: 16 months) following IVBT, all for symptoms suggested of restenosis. All patients had some degree of ISR of the target vessel, but no IVBT-treated vascular segment showed angiographic signs of degeneration, dissection or aneurysm. Conclusion: The authors' clinical impression, along with detailed review of the 10 cases, suggest that using a 34 Gy prescription dose at 2 mm from source center does not result in increased toxicity.

Original languageEnglish
Pages (from-to)1034-1039
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Issue number6
StatePublished - 15 Nov 2023
Externally publishedYes


  • brachytherapy
  • cardiac
  • coronary
  • dosimetry
  • radiation
  • restenosis


Dive into the research topics of 'Increased prescription dose for large vessel intravascular brachytherapy'. Together they form a unique fingerprint.

Cite this